University Health Network (UHN) is pleased to announce a $5-million philanthropic gift from BMO to support the construction of a new Surgical Tower at UHN’s Toronto Western Hospital and the expansion of PMATCH, an AI-powered precision oncology initiative at UHN’s Princess Margaret Cancer Centre.
“We’re proud to support UHN as they lead the way in transforming life-changing care for patients with cancer,” said Darryl White, CEO of BMO Financial Group and Campaign Cabinet Co-Chair of the UHN Surgical Tower Campaign. “This investment puts the patient first by fostering a culture of technology innovation, collaboration and empowerment, which are key contributors to the high-quality health care that strengthens our communities.”
BMO’s gift will play a critical role in advancing cancer treatment at both Princess Margaret Cancer Centre and UHN’s new Surgical Tower at Toronto Western Hospital, a first-of-its-kind initiative designed to meet the growing and increasingly complex surgical needs of patients across Ontario and beyond. Purpose-built to drive innovation, the Tower will significantly expand surgical capacity, modernize operating rooms and provide an elevated care journey for patients and their loved ones.
BMO’s gift will also support PMATCH, a world-first, AI-powered initiative that uses artificial intelligence to better connect cancer patients with the most suitable clinical trials – first at Princess Margaret Cancer Centre, and ultimately expanding to other participating Canadian hospitals. Using individual clinical and genomic profiles, PMATCH will improve patient screening through automation, streamline trial enrollment and support more efficient and equitable cancer research and care.
“This generous gift from BMO reflects the power of philanthropy to drive both innovation and collaboration across our healthcare system,” said Dr. Kevin Smith, President & CEO of University Health Network. “Support for the new Surgical Tower will help UHN meet the growing demand for complex surgical care, while this shared investment alongside The Princess Margaret to advance PMATCH will improve how patients are connected to clinical trials and accelerating discovery for patients across Canada.”
Together, these investments reflect a shared commitment to advancing patient-centred care through both state-of-the-art infrastructure and targeted innovation. By supporting the Surgical Tower and PMATCH, BMO’s gift will help expand access to care, accelerate discovery and strengthen Canada’s health care system for patients today and in the future.